Germany· DE-A57-e6450a10e8b1adeb
Letro-Cell
A letrozole product containing letrozole, registered in Germany by Stadapharm Gmbh. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Letrozole is registered in 18 of 19 countries.
Countries holding a registration under ATC L02BG04 (letrozole), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 11 of them publish a price we can compare per daily dose
Letrozole · ATC L02BG04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of letrozole costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $1.23 in France to $27.12 in United States — a ×22 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Letrozole · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- US United States$27.12 (acquisition cost)
- CH Switzerland$2.73
- IT Italy$2.51
- FR France$1.23
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Letrozole
- Manufacturer
- Stadapharm Gmbh
- Country
- Germany (DE)
- ATC code
- L02BG04
- ATC class
- Letrozole
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
311 interactions on record for letrozole.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Letrozole · interactions on record
311 records
- 2 severe
- 93 moderate
- 7 minor
- 209 info
Most severe, free to view
- ThalidomideL04AX02severe
- CitalopramN06AB04severe
- AprepitantA04AD12moderate
- LonafarnibA16AX20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Letrozole in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALETROPHARMAGEN CZ s.r.o., Praha
- SpainFEMARA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Farmaceutica S.A.
- ItalyBRESTORALWAVE PHARMA S.R.L.
- United KingdomFemara 2.5mg tabletsWaymade Healthcare Plc
- United StatesFemaraNovartis Pharmaceuticals Corporation
- SwitzerlandFemara
- FranceFEMARA 2,5 mg, comprimé pelliculéBB FARMA (ITALIE)
- CanadaACH-LETROZOLEACCORD HEALTHCARE INC
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Femara, Letrofam
- Belgium · Femara, Letrozol Sandoz
- Bulgaria · Етрузил, Зеквипра
- Cyprus · Femara, Feremazol
- Czechia · Aletro, Dracenax
- Denmark · Letrozol Accord, Letrozol Medical Valley
- Estonia · Femara, Feremazol
- Spain · Femara, Galdar
- Finland · Femar, Letrolan
- France · Femara, Letrozole Accord Healthcare
- United Kingdom (Northern Ireland) · Femara, Letrozole
- Greece · Femaplex, Femara
- Croatia · Avomit, Femara
- Hungary · Etruzil, Famos
- Ireland · Femara, Letrozole Accord Healthcare Ireland
- Iceland · Letromal, Letrozol Actavis
- Italy · Blormat, Brestoral
- Lithuania · Femara, Feremazol
- Luxembourg · Femara, Letrozole Eg
- Latvia · Femara, Letrozole Sanoswiss
- Malta · Femara, Feremazol
- Netherlands · Etruzil, Letrostar
- Norway · Femar, Letrozol Accord
- Poland · Aromek, Clarzole
- Portugal · Femara, Letrozol Accord
- Romania · Elozora, Etruzil
- Sweden · Letrozol Accord, Letrozol Medical Valley
- Slovenia · Femara, Letrozol Genthon
- Slovakia · Aletro, Etruzil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0eef3583-8db2-4b2a-9884-be81b1bd0a01 GET /v1/drugs/0eef3583-8db2-4b2a-9884-be81b1bd0a01?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Letrozole",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about letrozole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.